This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Biocare Copenhagen A/S
Biocare Copenhagen A/S, a leading name in the biotechnology sector, is headquartered in Denmark (DK) and operates extensively across Europe and beyond. Founded in 2005, the company has established itself as a pioneer in developing innovative biopharmaceutical solutions, focusing on areas such as immunology and oncology. Biocare's core offerings include advanced diagnostic tools and therapeutic products that leverage cutting-edge technology, setting them apart in a competitive market. With a commitment to quality and efficacy, the company has achieved significant milestones, including numerous regulatory approvals and partnerships with key industry players. Recognised for its expertise and innovation, Biocare Copenhagen A/S continues to strengthen its market position, contributing to advancements in healthcare and improving patient outcomes globally.
DitchCarbon Score
How does Biocare Copenhagen A/S's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Food Product Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biocare Copenhagen A/S's score of 77 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Biocare Copenhagen A/S, headquartered in Denmark (DK), currently does not report specific carbon emissions data for the most recent year. The company is a current subsidiary of DSM-Firmenich AG, which influences its climate commitments and emissions reporting. As part of its corporate family relationship, Biocare Copenhagen A/S inherits climate initiatives and targets from DSM-Firmenich AG. This includes participation in various sustainability frameworks such as the Science Based Targets initiative (SBTi), CDP, and RE100, all of which are cascaded from DSM-Firmenich AG. However, specific reduction targets or achievements for Biocare Copenhagen A/S are not detailed. While no absolute emissions numbers are available, the company's alignment with DSM-Firmenich AG's sustainability efforts indicates a commitment to reducing carbon emissions and enhancing climate resilience. The absence of direct emissions data suggests that Biocare Copenhagen A/S is in the process of developing its own reporting and reduction strategies, guided by the overarching goals of its parent organisation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 1,030,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 590,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 8,683,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - | 00,000,000,000 | 0,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biocare Copenhagen A/S is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
